Moreover, Nrf2 released by Keap1 deactivation induced lung cancer metastases through suppression of Bach1 (another pivotal regulator of EMT) degradation in a Ho-1-dependent manner, so targeting Ho-1 or Nrf2 blockade can decrease lung cancer metastases [119]. The gene discussed is NFE2L2; the disease is lung carcinoma.